Estados financieros detallados de GT Biopharma, Inc. (GTBP): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $7.81, GTBP presenta beneficios negativos (P/E no significativo) y un ROE del -443.08%. La capitalización bursátil es de $10M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1000 | $2000 | $7000 | $4000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$1000 | -$2000 | -$7000 | -$4000 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | $975000 | $1.1M | $9.1M | $1.7M | $485000 | $9.6M | $8.8M | $6.5M | $5.8M | $3.5M |
| Generales y Administrativos | $8.4M | $134.5M | $12.5M | $9.8M | $6.3M | $47.9M | $12.4M | $7.1M | $8.6M | $8.9M |
| Gastos Operativos | $9.4M | $135.6M | $21.6M | $11.5M | $6.8M | $57.5M | $21.3M | $13.6M | $14.4M | $12.4M |
| Beneficio Operativo | -$9.4M | -$135.6M | -$250.1M | -$11.5M | -$6.8M | -$57.5M | -$21.3M | -$13.6M | -$14.4M | -$12.4M |
| EBITDA | -$9.4M | -$135.6M | -$250.1M | -$36.5M | -$25.0M | -$57.5M | -$21.0M | $6.0M | -$13.2M | -$28.2M |
| Gastos por Intereses | $6.6M | $8.6M | $9.1M | $2.1M | $3.3M | $718000 | $8000 | $213000 | 0 | $127000 |
| Beneficio Antes de Impuestos | $9.8M | -$144.2M | -$259.2M | -$38.6M | -$28.3M | -$58.0M | -$20.9M | -$7.6M | -$13.2M | -$28.4M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | $9.8M | -$144.2M | -$259.2M | -$38.6M | -$28.3M | -$58.0M | -$20.9M | -$7.6M | -$13.2M | -$28.4M |
| BPA | $1530000.00 | $-3630.50 | $-2192.50 | $-285.50 | $-161.25 | $-51.50 | $-16.50 | $-141.00 | $-173.50 | $-156.25 |
| BPA Diluido | $1530000.00 | $-3630.50 | $-2192.50 | $-285.50 | $-161.25 | $-51.50 | $-16.50 | $-141.00 | $-173.50 | $-156.25 |
| Acciones en Circulación (Diluidas) | $6 | $39457 | $118200 | $135400 | $175400 | $1.1M | $1.3M | $53920 | $75880 | $220530 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $19000 | $576000 | $60000 | $28000 | $5.3M | $9.0M | $5.7M | $1.1M | $4.0M | $6.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $23.0M | $10.8M | $12.9M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $21000 | $576000 | $90000 | $274000 | $5.7M | $32.2M | $16.6M | $14.1M | $4.2M | $8.1M |
| Inmovilizado Material | $4000 | $6000 | $35000 | $110000 | 0 | 0 | $165000 | $53000 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | $253.8M | $25.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $25000 | $254.4M | $25.4M | $396000 | $5.7M | $32.2M | $16.7M | $14.1M | $4.2M | $8.1M |
| Cuentas por Pagar | $2.1M | $2.5M | $1.8M | $1.9M | $2.2M | $8.2M | $3.1M | $4.3M | $3.9M | $748000 |
| Deuda a Corto | $12.4M | $31000 | $10.8M | $13.2M | $26.3M | $31000 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $18.9M | $2.7M | $14.0M | $19.7M | $35.1M | $10.3M | $4.9M | $6.6M | $5.9M | $2.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $18.9M | $2.7M | $14.0M | $19.7M | $35.1M | $10.3M | $5.0M | $6.6M | $5.9M | $2.3M |
| Reservas | -$124.6M | -$269.5M | -$528.7M | -$567.3M | -$595.6M | -$653.6M | -$674.5M | -$682.1M | -$695.2M | -$723.9M |
| Patrimonio Neto | -$18.8M | $251.9M | $11.5M | -$19.1M | -$29.3M | $21.9M | $11.7M | $7.5M | -$1.7M | $5.8M |
| Deuda Total | $12.4M | $31000 | $10.8M | $13.4M | $26.3M | $31000 | $174000 | $58000 | 0 | 0 |
| Deuda Neta | $12.4M | -$545000 | $10.7M | $13.3M | $21.0M | -$31.9M | -$16.3M | -$13.9M | -$4.0M | -$6.8M |
| Capital Circulante | -$18.9M | -$2.1M | -$13.9M | -$19.4M | -$29.4M | $21.9M | $11.6M | $7.4M | -$1.7M | $5.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | $21.0M | -$143.2M | -$259.2M | -$38.6M | -$28.3M | -$58.0M | -$20.9M | -$7.6M | -$13.2M | -$28.4M |
| Amortizaciones | $1000 | $2000 | $7000 | $4000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $6.6M | $130.1M | $9.7M | $5.3M | $269000 | $33.9M | $7.6M | $2.2M | $230000 | $432000 |
| Cambio en Capital Circulante | $2.8M | $1.4M | $111000 | $4.1M | $2.4M | $7.9M | -$2.0M | $1.8M | $828000 | -$920000 |
| Flujo de Caja Operativo | -$1.9M | -$5.4M | -$10.7M | -$3.7M | -$7.3M | -$15.6M | -$15.2M | -$8.9M | -$12.9M | -$12.9M |
| Inversiones (CapEx) | 0 | -$4000 | -$36000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$224000 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$229000 |
| Flujo de Caja Libre | -$1.9M | -$5.4M | -$10.7M | -$3.7M | -$7.3M | -$15.6M | -$15.2M | -$8.9M | -$12.9M | -$12.9M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -1576.0% | -79.8% | +85.1% | +26.8% | -105.0% | +64.0% | +63.6% | -73.3% | -115.4% | |
| Crecimiento BPA (anual) | -100.2% | +39.6% | +87.0% | +43.5% | +68.1% | +68.0% | -754.5% | -23.0% | +9.9% | |
| Cambio en Acciones (anual) | +657516.7% | +199.6% | +14.6% | +29.5% | +542.1% | +13.2% | -95.8% | +40.7% | +190.6% | |
| Crecimiento FCF (anual) | -181.6% | -97.1% | +65.8% | -98.5% | -114.9% | +2.5% | +41.8% | -45.8% | -0.1% | |
| Tasa Impositiva Efectiva | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-321666.67 | $-137.72 | $-90.63 | $-27.02 | $-41.40 | $-13.86 | $-11.94 | $-164.17 | $-170.06 | $-58.56 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.04 |
| Acciones en Circulación (Básicas) | $6 | $39457 | $118200 | $135400 | $175400 | $1.1M | $1.3M | $53880 | $75880 | $220530 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -443.08% |
| Rentabilidad sobre capital invertido | -457.75% |
| Rentabilidad sobre activos | -381.53% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 2.61 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -128.11 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | 0.24 | -15.63 | -3.78 | -3.62 | -33.53 | -44.42 | -40.26 | -1.36 | -0.44 | -0.13 |
| P/VC | -0.12 | 8.89 | 84.89 | -7.31 | -32.40 | 117.58 | 72.16 | 1.38 | -3.46 | 0.75 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: ARTL · CARM · DRMA · LIPO · PBM · PTIX · REVB
Explorar sector: Healthcare · Biotechnology
Más secciones de GTBP: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones